In re Donald L.

Illinois Official Reports

Appellate Court

In re Donald L., 2014 IL App (2d) 130044

Appellate Court In re DONALD L., Alleged to be a Person Subject to Involuntary
Caption Treatment (The People of the State of Illinois, Petitioner-Appellee, v.
Donald L., Respondent-Appellant).

District & No. Second District
Docket No. 2-13-0044

Filed February 5, 2014

Held Although the order allowing respondent’s doctors to administer
(Note: This syllabus unspecified tests had expired and his appeal was moot, the issue was
constitutes no part of the considered under the public-interest exception, and since the order
opinion of the court but allowing “other tests necessary to evaluate safe administration of
has been prepared by the medications” was not supported by any evidence as to what the tests
Reporter of Decisions might be, the order was reversed on the ground that it violated section
for the convenience of 2-107.1(a-5)(4)(G) of the Mental Health and Developmental
the reader.) Disabilities Code.

Decision Under Appeal from the Circuit Court of Kane County, No. 12-MH-126; the
Review Hon. Kathryn D. Karayannis, Judge, presiding.

Judgment Reversed.
 Counsel on Veronique Baker, of Guardianship & Advocacy Commission, of
Appeal Chicago, and Ann Krasuski, of Guardianship & Advocacy
Commission, of Hines, for appellant.

Joseph H. McMahon, State’s Attorney, of St. Charles (Lawrence M.
Bauer and Diane L. Campbell, both of State’s Attorneys Appellate
Prosecutor’s Office, of counsel), for the People.

Panel JUSTICE HUDSON delivered the judgment of the court, with
opinion.
Justices Jorgensen and Birkett concurred in the judgment and opinion.

OPINION

¶1 Respondent, Donald L., appeals the trial court’s order authorizing the involuntary
administration of psychotropic medication and testing for up to 90 days under section
2-107.1(a-5)(4) of the Mental Health and Developmental Disabilities Code (Code) (405 ILCS
5/2-107.1(a-5)(4) (West 2012)). Respondent contends that the trial court failed to comply with
the Code when it allowed his doctors to administer unspecified tests. He also contends that the
court erred in finding that he lacked capacity to make a reasoned decision about medication.
We agree with respondent’s first contention and reverse on that point.

¶2 I. BACKGROUND
¶3 On November 8, 2012, respondent was involuntarily admitted to the Elgin Mental Health
Center after being adjudicated unfit to stand trial for possession of a weapon. He had
previously been involuntarily admitted from February 17, 2011, to April 25, 2011. After that,
he was living in the community and receiving mental health treatment.
¶4 On November 21, 2012, respondent’s treating psychiatrist, Dr. Mirella Susnjar, sought an
order authorizing the involuntary administration of psychotropic medication, testing, and
medical procedures. On December 7, 2012, a hearing was held.
¶5 Susnjar testified that respondent was diagnosed with schizophrenia, undifferentiated type,
which is a serious mental illness. She said that respondent heard voices that he perceived as
real. Respondent believed that the Mormon Church was a threat to him and that the voices
were warning him about it. Susnjar said that respondent demonstrated symptoms such as
hallucinations and difficulty socializing with people. In her opinion, respondent displayed
unreasonable fears and false beliefs, which made him unable to appreciate his problems or
make decisions about medication. She opined that his mental illness caused a deterioration of
his ability to function, including making him unfit to stand trial.
-2-
¶6 Susnjar stated that respondent did not believe that he had a mental illness. She said that she
spoke with him four times to discuss medication and that he said that he would not take it,
expressing strong beliefs that the medications would hurt him, make him fat, possibly cause
him to transfer birth defects to his future partner, and cause side-effects that he previously
experienced with psychotropic medications.
¶7 Susnjar requested to administer risperidone, olanzapine, quetiapine, and aripiprazole for
psychosis and haloperidol and lorazepam for anxiety. She also requested diphenhydramine
(Benadryl) and benztropine to address side-effects. She testified specifically about each
medication and stated why she selected it. Susnjar said that she chose medications that would
be comfortable for respondent to use, but there were also 15 alternate medications she could
offer for respondent to choose from.
¶8 The petition sought to administer the following tests and procedures:
“Physical exam, weight, vitals: blood pressure, pulse, respiration, temperature, blood
work: CBC and differential, BUN and creatine, liver function tests, lipid panel, thyroid
tests, and other tests necessary to evaluate safe administration of medications, level of
medication in blood, EKG if necessary.”
¶9 Susnjar was asked to outline the tests and procedures she requested, and she stated:
“Blood pressure, pulse, temperature, blood work in a sense of monitoring the health of
blood, and it can be CBC and differential, address the function of the kidneys, liver
function test, TSH, thyroid testing, lipid testing, because as I said sometimes people
can start to gain weight and we monitor that very carefully. Any test that is necessary to
assure a safe administration of medications. EKG if necessary, as well as level of
medication in blood.”
There was no further description or explanation of the tests.
¶ 10 Respondent testified about his previous involuntary commitment, during which he was
also diagnosed with schizophrenia, undifferentiated type, and was treated with medications.
He said that he was initially given only risperidone and that he suffered side-effects.
Respondent stated that his “face swelled up like a punching bag,” that he “walked around like a
zombie,” and that his speech was slurred. The next day the doctors adjusted the dose and gave
him what he testified was Benadryl, but was actually benztropine, to address the side-effects.
He said that the side-effects were not alleviated, as his face remained swollen and his speech
slurred. He said that the side-effects were reported daily.
¶ 11 Respondent testified that he continued the medications for six months after he was
discharged but saw no changes in his symptoms, while he continued to experience side-effects
such as dizziness, excessive dry mouth, blurred vision, speech impairment, inattentiveness,
disorientation, decreased cognitive performance, swelling of the face and neck, pressure in his
ears, and hearing echoes. He also gained 45 pounds, although his appetite decreased.
Respondent said that the excess weight affected preexisting hip and sciatic pain. He needed
hip-replacement surgery and estimated that he needed to lose 15 to 20 pounds to decrease the
pressure on his sciatic nerve. Respondent met with a psychiatrist who gave him Geodon, but
the side-effects still remained except for the swelling of the face and neck. He also saw a

-3-
 general practitioner because of a stomach ulcer and was told that it was caused by the
medications. Respondent quit taking the medications before his arrest on July 24, 2012. He
said that the medications never helped his symptoms of schizophrenia and that the
went away when he stopped taking the medications.
¶ 12 Respondent said that, because of the side-effects he previously experienced, he did not
consent to taking medications. He said that he would take part in other forms of treatment.
However, he admitted that he attended group therapy only 5 times in 30 days, although
Susnjar told him that he should attend every day. He did not attend many groups because he
believed that Susnjar knew he could answer questions when asked.
¶ 13 Susnjar was not aware of the numerous side-effects that respondent reported. No medical
records showed that respondent experienced side-effects other than those after the initial dose
of risperidone. According to Susnjar, the discharge records showed that, after he was given
benztropine, no debilitating side-effects were reported. She also noted that the dose of
risperidone had been decreased and that respondent previously told her that his swelling was
reduced after he took Benadryl. She stated that side-effects are possible, especially with high
doses, but she was not aware of patients gaining weight while having less appetite. She
agreed that more weight on respondent’s joints would be a problem. Susnjar stated that she
would suggest different dosages or medications if side-effects occurred. However, she said
that side-effects can also be associated with other medications. In her opinion, respondent
was suffering, the benefits of psychotropic medication would outweigh the harm, and
respondent did not have the capacity to make a reasoned decision about medication.
¶ 14 Susnjar stated that respondent was receptive to groups and was able to answer a lot of
fitness questions in them. However, she believed that group therapy would not change
respondent’s opinion of the world and would not stabilize him unless accompanied by
medication.
¶ 15 The court found that Susnjar provided clear and convincing evidence that there was a
need to administer psychotropic medication against respondent’s will and that the benefits
outweighed the harm. In regard to the side-effects, the court expressed concern but also noted
that the side-effects were self-reported. It then found that, although respondent believed that
there were risks, he lacked the capacity to make a decision on the matter. The court found
that respondent did not understand the advantages and disadvantages of medications and did
not understand how they previously restored him to fitness and how he became unfit again
when not taking them. The court granted the petition, authorizing the involuntary
administration of psychotropic medications for up to 90 days. In regard to tests, it quoted the
petition in its order, allowing certain specified tests but also “other tests necessary to evaluate
safe administration of medications.” Respondent appeals.

¶ 16 II. ANALYSIS
¶ 17 Relying on the Fifth District case of In re Larry B., 394 Ill. App. 3d 470 (2009),
first contends that the trial court failed to comply with section 2-107.1(a-5)(4)(G) of the Code
(405 ILCS 5/2-107.1(a-5)(4)(G) (West 2012)) when it allowed his doctors to administer

-4-
 unspecified tests. Respondent recognizes that the matter is moot because the order for
administration of medication was for 90 days, which time has passed. However, he argues
that exceptions to the mootness doctrine apply. The State agrees that exceptions apply.
¶ 18 “An appeal is considered moot where it presents no actual controversy or where the
issues involved in the trial court no longer exist because intervening events have rendered it
impossible for the reviewing court to grant effectual relief to the complaining party.” In re
J.T., 221 Ill. 2d 338, 349-50 (2006). Generally, courts of review do not decide moot
questions, render advisory opinions, or consider issues where the result will not be affected
regardless of how those issues are decided. In re Barbara H., 183 Ill. 2d 482, 491 (1998).
¶ 19 Reviewing courts, however, recognize exceptions to the mootness doctrine: (1) the
public-interest exception, applicable where the case presents a question of public importance
that will likely recur and whose answer will guide public officers in the performance of their
duties, (2) the capable-of-repetition exception, applicable to cases involving events of short
duration that are capable of repetition, yet evading review, and (3) the
collateral-consequences exception, applicable where the order could have consequences for a
party in some future proceedings. See In re Alfred H.H., 233 Ill. 2d 345, 355-62 (2009).
There is no per se exception to mootness that universally applies to mental health cases;
however, most appeals in mental health cases will fall within one of the established
exceptions. Id. at 355. Whether a case falls within an established exception is a case-by-case
determination. Id.
¶ 20 “The public interest exception allows a court to consider an otherwise moot case when
(1) the question presented is of a public nature; (2) there is a need for an authoritative
determination for the future guidance of public officers; and (3) there is a likelihood of future
recurrence of the question.” Id. “The ‘public interest’ exception is ‘narrowly construed and
requires a clear showing of each criterion.’ ” Id. at 355-56 (quoting In re Marriage of
Peters-Farrell, 216 Ill. 2d 287, 292 (2003)). Questions about compliance with the Code
involve matters of substantial public interest. In re Nicholas L., 407 Ill. App. 3d 1061, 1071
(2011).
¶ 21 Here, respondent raises an issue of statutory compliance that is a matter of a public
nature. The only case addressing respondent’s argument is from another appellate district,
showing a need for an authoritative determination of the matter. Further, without an
authoritative determination of the matter from this district, it is likely to recur. Accordingly,
the public-interest exception applies.
¶ 22 The involuntary administration of psychotropic medication to an individual alleged to be
mentally ill implicates substantial liberty interests. In re C.E., 161 Ill. 2d 200, 213-17 (1994).
However, these liberty interests must be balanced against the State’s legitimate interests in
furthering the treatment of mentally ill individuals by forcibly administering psychotropic
medication where an individual lacks the capacity to make reasoned decisions concerning his
or her need for such medication. Id. at 217. In 1991, the General Assembly enacted section
2-107.1 as a mechanism for determining when psychotropic medication may be administered
over an individual’s objections. Id. Section 2-107.1 serves as a guide for balancing the liberty
of the individual and the State’s interest in treating its mentally ill citizens. Id.
-5-
¶ 23 Section 2-107.1(a-5)(4) directs that the forced administration of psychotropic medication
is authorized only if the court finds each of the following elements, by clear and convincing
proof:
“(A) That the recipient has a serious mental illness or developmental disability.
(B) That because of said mental illness or developmental disability, the recipient
currently exhibits any one of the following: (i) deterioration of his or her ability to
function, as compared to the recipient’s ability to function prior to the current onset of
symptoms of the mental illness or disability for which treatment is presently sought,
(ii) suffering, or (iii) threatening behavior.
(C) That the illness or disability has existed for a period marked by the continuing
presence of the symptoms set forth in item (B) of this subdivision (4) or the repeated
episodic occurrence of these symptoms.
(D) That the benefits of the treatment outweigh the harm.
(E) That the recipient lacks the capacity to make a reasoned decision about the
treatment.
(F) That other less restrictive services have been explored and found
inappropriate.
(G) If the petition seeks authorization for testing and other procedures, that such
testing and procedures are essential for the safe and effective administration of the
treatment.” 405 ILCS 5/2-107.1(a-5)(4) (West 2012).
¶ 24 We have not previously addressed a trial court order that broadly allowed “other tests
necessary to evaluate safe administration of medications.” However, In re Larry B. from the
Fifth District provides guidance.
¶ 25 There, a petition was filed seeking the involuntary administration of medication and
testing. The petition stated that the respondent would need periodic blood tests to monitor the
level of drugs in his system and to prevent side-effects. At the hearing, the respondent’s
psychiatrist did not testify about the nature of the tests that he sought to administer. Instead,
he was asked if he wanted the court to allow him to “ ‘do the testing and procedures
necessary to make sure [that the administration of psychotropic medication was] safely and
effectively done,’ ” and he replied “ ‘Yes.’ ” In re Larry B., 394 Ill. App. 3d at 478.
Medication and testing were ordered, and the respondent appealed. The Fifth District held
that there was a lack of compliance with section 2-107.1(a-5)(4)(G). Noting that the State
was required to prove by clear and convincing evidence that the testing and procedures
requested in the petition were “ ‘essential for the safe and effective administration of the
treatment,’ ” the court held that the evidence was insufficient. Id. (quoting 405 ILCS
5/2-107.1(a-5)(4)(G) (West 2008)). The court found that it “fell far short of clear and
convincing specific expert testimony in support of a request for testing” and that the trial
court’s grant of permission to perform the tests “was made in an informational limbo, not a
fully informed state, warranting the reversal of the trial court’s order.” Id.
¶ 26 Our approach to the sufficiency of the evidence for the administration of medication is
also instructive. In that context, section 2-107.1 establishes strict standards that must be
-6-
 satisfied before medication may be ordered over the objection of a patient. 405 ILCS
5/2-107.1(a-5)(4) (West 2012); In re C.E., 161 Ill. 2d at 218. The Code requires specific
evidence of the benefits and risks of each medication so that the trial court can determine
whether the State has demonstrated by clear and convincing evidence that the benefits of the
proposed treatment outweigh the potential harm. In re Suzette D., 388 Ill. App. 3d 978, 985
(2009). “Thus, the State must produce evidence of the benefits of each drug sought to be
administered as well as the potential side effects of each drug.” Id. The trial court may not
“delegate[ ] its duty of assessing the risks and benefits of the medication to respondent’s
treating physicians.” In re Val Q., 396 Ill. App. 3d 155, 163 (2009). The same logic applies to
the administration of tests. Without specific evidence, a court is unable to determine which
tests are essential to the safe and effective administration of treatment as required by the
Code. The court may not delegate that determination to the respondent’s doctors by allowing
them to administer unspecified tests as they see fit.
¶ 27 Here, the court authorized “other tests necessary to evaluate safe administration of
medications” without any evidence of what those tests might be. By doing so, the court
allowed unknown tests to be administered absent clear and convincing evidence that they
were “essential for the safe and effective administration of the treatment.” 405 ILCS
5/2-107.1(a-5)(4)(G) (West 2012). That is, the court delegated its duty to Susnjar, allowing
her to administer any test that she deemed essential. That is contrary to section
2-107.1(a-5)(4)(G). Accordingly, we reverse.
¶ 28 Although our holding with respect to compliance with the Code is dispositive, we
nonetheless address respondent’s next argument, that the trial court’s determination that he
lacked the capacity to make a reasoned decision was against the manifest weight of the
evidence. See In re Nicholas L., 407 Ill. App. 3d at 1074 (noting that resolution of the first
issue was dispositive but nonetheless addressing respondent’s remaining sufficiency-
of-the-evidence argument).
¶ 29 Respondent’s argument falls under the exception to the mootness doctrine for matters
capable of repetition yet evading review. “This exception has two elements. First, the
challenged action must be of a duration too short to be fully litigated prior to its cessation.
Second, there must be a reasonable expectation that ‘the same complaining party would be
subjected to the same action again.’ ” In re Alfred H.H., 233 Ill. 2d at 358 (quoting In re
Barbara H., 183 Ill. 2d 482, 491 (1998)). “This means that the present action and a potential
future action must have a substantial enough relation that the resolution of the issue in the
present case would have some bearing on a similar issue presented in a future case involving
the respondent.” In re Val Q., 396 Ill. App. 3d at 160 (citing In re Alfred H.H., 233 Ill. 2d at
360).
¶ 30 Here, respondent had received similar psychotropic medications in the recent past and is
suffering from a chronic mental illness that can inhibit his ability to make a reasoned
decision about treatment. Thus, it is reasonably likely that he will be subjected to similar
involuntary treatment orders in the future. See In re Suzette D., 388 Ill. App. 3d at 983. “Also,
the challenged action is obviously too short to be fully litigated during the pendency of the

-7-
 order.” Id. at 983-84. Accordingly, the capable-of-repetition exception is applicable to
respondent’s claim. See id. at 984.
¶ 31 “An individual has the capacity to make treatment decisions for himself when, based
upon conveyed information concerning the risks and benefits of the proposed treatment and
reasonable alternatives to treatment, he makes a rational choice to either accept or refuse the
treatment.” In re Israel, 278 Ill. App. 3d 24, 36 (1996). When determining whether an
individual has the capacity to make a reasoned decision whether to take psychotropic
medication, the trial court should consider the following factors:
“(1) The person’s knowledge that he has a choice to make;
(2) The person’s ability to understand the available options, their advantages and
disadvantages;
(3) Whether the commitment is voluntary or involuntary;
(4) Whether the person has previously received the type of medication or
treatment at issue;
(5) If the person has received similar treatment in the past, whether he can
describe what happened as a result and how the effects were beneficial or harmful;
and
(6) The absence of any interfering pathologic perceptions or beliefs or interfering
emotional states which might prevent an understanding of legitimate risks and
benefits.” Id. at 37.
None of these factors is dispositive, and other factors that are relevant should be considered.
Id.
¶ 32 As a reviewing court, we give great deference to the trial court’s factual findings, but will
reverse an order allowing the involuntary administration of psychotropic medication when
the trial court’s findings are against the manifest weight of the evidence. In re Val Q., 396 Ill.
App. 3d at 162. A judgment will be considered against the manifest weight of the evidence
“only when an opposite conclusion is apparent or when the findings appear to be
unreasonable, arbitrary, or not based on evidence.” In re John R., 339 Ill. App. 3d 778, 781
(2003).
¶ 33 Here, the trial court’s finding was not against the manifest weight of the evidence.
Although the evidence showed that respondent knew that he had a choice about medication,
Susnjar testified that he was unable to understand the advantages and disadvantages of
medication because his fears and false beliefs made him unable to appreciate his problems.
Supporting that view were the facts that respondent was involuntarily admitted, he did not
believe that he had a mental illness, and he did not attend group treatment as suggested.
Further, although he previously received several of the medications prescribed, there was a
conflict of evidence on how he tolerated those. Respondent reported numerous side-effects,
while Susnjar noted medical reports that were inconsistent with his testimony and showed
that he responded to treatments for side-effects. The trial court, as the finder of fact, was
entitled to credit Susnjar’s testimony based on medical records over respondent’s testimony.

-8-
¶ 34 Based on the evidence as a whole, it was reasonable to conclude that respondent lacked
the ability to understand the risks and benefits of taking medication. Accordingly, the trial
court’s finding that respondent lacked the capacity to make a reasoned decision was not
against the manifest weight of the evidence.

¶ 35 III. CONCLUSION
¶ 36 The evidence was sufficient to prove that respondent lacked the capacity to make a
reasoned decision about medication. However, the trial court failed to comply with the Code
when it allowed respondent’s doctors to administer unspecified tests. Accordingly, the
judgment of the circuit court of Kane County is reversed.

¶ 37 Reversed.

-9-